Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
03/2004
03/30/2004US6713580 Quaternary amino acids on solid supports
03/30/2004US6713464 Derivatives of 3,3-diphenylpropylamines
03/30/2004CA2194502C 2-[1',2',4'-triazol-3'-yloxymethylene]anilides, their preparation and their use
03/30/2004CA2130755C Intermediates useful in the preparation of purine nucleoside analogues
03/25/2004WO2004024755A2 Sarcolysyl derivatives and method for the production thereof
03/25/2004WO2004024737A1 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms
03/25/2004WO2004024081A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
03/25/2004WO2003104167A3 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates
03/25/2004WO2003069350A3 Small molecule modulators of apoptosis
03/25/2004WO2003066549A3 Synthesis of sulfamidates
03/25/2004WO2002088085A3 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors
03/25/2004US20040059158 Method of friedel-crafts acylation of anilides
03/25/2004US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof
03/25/2004US20040059129 2,5-bisphenyl-delta1-pyrroline derivative are chromatographed on a stationary chiral silica gel phase in presence of an eluent or mixture as liquid phase
03/25/2004US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
03/25/2004CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes
03/24/2004EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
03/24/2004EP1399148A2 Multifunctional carbonates and derivatives
03/24/2004EP1318990B1 Process for preparing optically active epoxides
03/24/2004EP1285018B1 Radically polymerisable compositions containing monofunctional monomers, resins and ophthalmic articles obtained from them, new monofunctional monomers
03/24/2004CN1142922C Intermediate used in preparing oxidiazine and its manufacturing method
03/24/2004CN1142904C One-step process synthetizing 2-oxazolidone derivative interediate and preparation process thereof
03/23/2004US6710203 Reacting aqueous ammonium hydroxide and a cyclic carbonate to obtain hydroxyalkylcarbamate
03/23/2004US6710200 Using reporter molecule derivative having aldehyde or ketone group detectable by fluorescence emission, ultraviolet radiation, absorptivity or colorimetric analysis; rearrangements
03/23/2004US6710157 Adding the polycarbamates to regulate the viscosity of the coatings automotives finishes
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/18/2004WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/18/2004WO2004001055A3 Pna prodrugs
03/18/2004WO2003099192A3 Bis-aromatic alkanols
03/18/2004WO2003018535A3 Novel aminobenzoephenones
03/18/2004US20040054216 Method for producing lysine derivative
03/18/2004DE10239832A1 New sarcolysine derivatives, e.g. amide or peptide compounds, useful as anticancer agents with reduced toxicity to healthy cells
03/18/2004CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives
03/17/2004EP1398310A1 Process for the production of optically active amino alcohols
03/17/2004EP1397382A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/17/2004EP1397362A2 Triazolopyrimidines having a fungicidal effect
03/17/2004EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
03/17/2004EP0998488B1 Polyol-amino acid compounds having anti-helicobacter pylori activity
03/17/2004CN1483017A Process for the production of 1, 5-naphthalenediamine
03/16/2004US6706924 Process for the production of 1,5-naphthalenediamine
03/16/2004US6706881 Methods for preparing CETP inhibitors
03/16/2004US6706796 For latex; stable suspension
03/16/2004CA2139348C Improved chemiluminescent 1,2-dioxetanes
03/11/2004WO2004020385A1 Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof
03/11/2004WO2004020384A1 Process for preparing nitrooxyderivatives of naproxen
03/11/2004WO2003097587A3 Gelling agents
03/11/2004US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/11/2004US20040048894 Compounds which mimic the chemical and biological properties of discodermolide
03/11/2004US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions.
03/11/2004US20040048834 Antitumoral compounds
03/11/2004US20040048797 Regulation of TNF-alpha
03/11/2004US20040047709 Locking nut, bolt and clip systems and assemblies
03/11/2004DE10240260A1 Formation of heteroatom-carbon bonds, giving products of interest for the pharmaceutical and agrochemical industries, comprises using an organolithium compound prepared by reacting an aliphatic or aromatic halide with lithium
03/10/2004EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
03/10/2004EP1085010B1 Phenylacetylene derivatives and agricultural/horticultural bactericides
03/10/2004EP1084101B1 New 3-aryl-2-hydroxypropionic acid derivative iii
03/10/2004CN1481369A Substituted phenyluracils compound
03/10/2004CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours
03/09/2004US6703522 Alkyl amino acid derivatives useful as pharmaceutical agents
03/09/2004US6703467 Adhesives and sealants
03/09/2004US6702705 Prodrugs activated by targeted catalytic proteins
03/04/2004WO2003088917A3 Regulation of tnf-alpha
03/04/2004WO2002038540A9 Activity-dependent cysteine protease profiling reagent
03/04/2004US20040044242 Using a trifluorosulfonate salt of bismuth, rare earth eleements
03/04/2004US20040044233 Nucleophilic kinetic resolution of cyclic substrates using silyl azides
03/04/2004US20040044201 Bone disorders; osteoporosis; oral diseases; antiarthritic agents
03/04/2004US20040044072 Substituted hydroxyethylamines
03/03/2004EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
03/03/2004EP1392695A2 Triazolopyrimidines
03/03/2004EP1392693A1 Triazolopyrimidines
03/03/2004EP1392655A2 Potassium channel openers
03/03/2004EP1392279A1 Trimethyl lock based tetrapartate prodrugs
03/03/2004EP1392204A2 Bifunctional energy-reversible acyl-compositions
03/03/2004EP0929217B1 Sordarin derivatives
03/03/2004CN1479718A Aryl and heteroarylcyclopropyl oximie ethers and their use as fungicides
03/03/2004CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes
03/03/2004CN1479714A Optically active amine derivative and method of synthesis
03/03/2004CN1140505C Improved method for synthesizing amino formic acid ester compound
03/02/2004US6699994 Biaryl compounds as serine protease inhibitors
03/02/2004US6699904 PPAR agonists
03/02/2004US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims
03/02/2004US6699893 Glucocorticoid receptor modulators
03/02/2004US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration
02/2004
02/26/2004WO2004016580A2 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid
02/26/2004WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof
02/26/2004US20040039224 T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them
02/26/2004US20040039038 Biaromatic compound activators of PPARy-type receptors
02/26/2004US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease
02/26/2004US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours
02/26/2004US20040037802 Activated polymeric bicine derivatives such as polypeptides modified with these polymers exhibit reduced immunogenicity/antigenicity and circulate in the blood
02/26/2004CA2497347A1 R(+)-2-amino-3-hydroxypropanoic acid derivatives with glycinergic action
02/25/2004EP1390342A2 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof
02/25/2004EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
02/25/2004EP1005446B1 N-aroylphenylalanine derivatives
02/25/2004EP0873301B1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity
02/24/2004US6696571 Process for producing α-aminoketones
02/24/2004US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease
02/24/2004US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives
02/24/2004US6696475 Substituted phenyl derivatives, their preparation and use
02/24/2004US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 157